MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
46.91
-0.28
-0.59%
After Hours: 47.49 +0.58 +1.24% 19:59 07/18 EDT
OPEN
48.74
PREV CLOSE
47.19
HIGH
48.80
LOW
45.50
VOLUME
1.49M
TURNOVER
--
52 WEEK HIGH
130.00
52 WEEK LOW
6.76
MARKET CAP
345.13M
P/E (TTM)
-0.0239
1D
5D
1M
3M
1Y
5Y
1D
Tonix Pharma Plans Sales Force for TNX-102 SL
TipRanks · 3d ago
Weekly Report: what happened at TNXP last week (0707-0711)?
Weekly Report · 5d ago
Tonix up after peer reviewed data for pain therapy and new data for mpox vaccine
Seeking Alpha · 07/10 16:08
Tonix Pharma Unveils Promising TNX-801 Vaccine Findings
TipRanks · 07/10 11:28
Tonix Pharmaceuticals to present new data on mpox and smallpox vaccine candidate
TipRanks · 07/10 11:16
Tonix Pharma Presents New Findings On TNX-801, Recombinant Horsepox, Live Virus Vaccine, At Vaccine Congress 2025 In Vienna
Benzinga · 07/10 11:16
TONIX PHARMACEUTICALS ANNOUNCES PRESENTATION OF NEW DATA ON MPOX AND SMALLPOX VACCINE CANDIDATE TNX-801 AT THE VACCINE CONGRESS 2025
Reuters · 07/10 11:00
Tonix Pharma Publishes Phase 3 Trial Results
TipRanks · 07/09 20:52
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.